FORM4API
ExploreSearch any ticker for its insider tradesFilingsThe newest Form 4 filings, market-wideForm 144Intent to sell, filed before the trade13F FilersInstitutional 13F-HR filers by AUMSignalsCluster buy & sell signalsScreenerFilter trades by code, size & returnCongressSTOCK Act trades disclosed by Congress
PricingDocs
SEC Form 4 explainedSEC Form 144 explained13F-HR filings explainedCluster buy signals10b5-1 trading plans
All guides →
Sign inGet a key

Company profile

CNS Pharmaceuticals, Inc. Insider Trading

CNSP

Every SEC Form 4 insider trading filing for CNS Pharmaceuticals, Inc. (CNSP) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001729427
Filings
50
Insiders
15
Last filing
2026-08-14
SEC EDGAR ↗Yahoo Finance ↗Finviz ↗Stock Analysis ↗

Activity summary

No insider transactions in the last 30 days. The most recent was on August 14, 2026, when Rami Levin bought 4,750 shares. 50 filings from 15 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q4 23 to Q3 26. CNS Pharmaceuticals, Inc. insiders are net buyers across the period shown.

PurchasesSales
Q4 23$90KQ1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $90K.

90 day insight

Over the last 90 days, CNS Pharmaceuticals, Inc. insiders bought $0 across 2 transactions with no open-market sales.

  • Most active insider: Rami Levin with 2 transactions totaling $0.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValueReturn
Aug 14, 2026Rami LevinCNSP
Option Exercise
4,750——-12.6% 1m
Aug 14, 2026Rami LevinCNSP
Option Exercise
4,750——-12.6% 1m
May 18, 2026Faith L. CharlesCNSP
Purchase
7,100$4.79$34K+24.3% 3m
May 18, 2026Michal FisherCNSP
Purchase
2,000$5.00$10K-12.6% 1m
Mar 2, 2026Steve O'LoughlinCNSP
Award
9,500——+95.1% 6m

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=CNSP" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

John M ClimacoChief Executive Officer1 filing+$50K
Faith L. CharlesDirector1 filing+$34K
Christopher DownsChief Financial Officer1 filing+$20K
Michal FisherDirector1 filing+$10K
Carl Anthony EvansDirector1 filing+$10K

Institutional Ownership

Top 13F-HR holders of CNS Pharmaceuticals, Inc. as of 2026-06-30

— stable
Total reported AUM
$43
QoQ change
—
Reporting period
2026-06-30
#1
Barrett & Company, Inc.
CIK 0000887602
$38
8 shares
#2
Danske Bank A/s
CIK 0000800177
$5
1 shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

FORM4API

Real-time SEC Form 4, Form 144, 13F-HR and congressional trading data, over a REST API and webhooks.

Data
  • Screener
  • Filings
  • Signals
  • Companies
  • Insiders
  • Congress trades
  • 13F filers
  • Explorer
  • Top insiders
Developers
  • Documentation
  • Insider trading API
  • Python SDK
  • TypeScript SDK
  • MCP server
  • Status
Company
  • Pricing
  • Guides
  • Compare
  • About
  • Data quality
  • Privacy
  • Terms
Form4API, StockholmNot affiliated with the SEC or EDGAR. Data sourced from public EDGAR filings. Not investment advice.

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.

TEAMAtlassian CorpLEGLeggett & Platt IncVZVerizon Communications IncTPLTexas Pacific Land CorpCRMSalesforce, Inc.RCGRENN Fund, Inc.METAMeta Platforms, Inc.ACNAccenture plcPPGPpg Industries IncNFLXNetflix IncCHDChurch & Dwight Co Inc /de/